COPD Assessment and Management Bundle Versus Usual Care

NACompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DEVICE

Spirometry test

For the initial visit for the intervention group, an initial demographics form and a health questionnaire will given to the subject to complete. To evaluate the breathing and quality of living, a spirometry test will be performed that will evaluate how well and how fast the subject can breath and blow out air.

DRUG

Levalbuterol

The spirometry test will be performed with a breathing medication called Levalbuterol (Xopenex®). Levalbuterol is used in standard practice for COPD and is commonly used during spirometry.

Trial Locations (1)

60612

University of Illinois, Chicago

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Illinois at Chicago

OTHER

NCT01833026 - COPD Assessment and Management Bundle Versus Usual Care | Biotech Hunter | Biotech Hunter